EyePoint Pharmaceuticals Inc (EYPT)
12.21
-7.53
(-38.15%)
USD |
NASDAQ |
May 06, 11:11
EyePoint Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.4422 |
| December 31, 2022 | 0.4128 |
| September 30, 2022 | 0.2914 |
| June 30, 2022 | 0.262 |
| March 31, 2022 | 0.2373 |
| December 31, 2021 | 0.1983 |
| September 30, 2021 | 0.3924 |
| June 30, 2021 | 0.3391 |
| March 31, 2021 | 0.3295 |
| December 31, 2020 | 2.048 |
| September 30, 2020 | 6.686 |
| June 30, 2020 | 12.00 |
| March 31, 2020 | 2.896 |
| December 31, 2019 | 5.669 |
| September 30, 2019 | 2.932 |
| June 30, 2019 | 1.640 |
| March 31, 2019 | 1.608 |
| September 30, 2018 | 0.3661 |
| June 30, 2018 | 1.481 |
| March 31, 2018 | 1.568 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
12.00
Maximum
Jun 2020
1.936
Average
0.3924
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| INVO Bioscience Inc | 3.096 |
| Bio-Path Holdings Inc | -- |
| Ocular Therapeutix Inc | 0.8222 |
| Aileron Therapeutics Inc | -- |
| Apellis Pharmaceuticals Inc | 0.4783 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 355.18M |
| Total Liabilities (Quarterly) | 88.86M |
| Shareholders Equity (Quarterly) | 266.32M |
| Current Ratio | 5.450 |
| Net Debt Paydown Yield | 0.70% |